Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients

J Hepatol. 2019 Jan;70(1):206-209. doi: 10.1016/j.jhep.2018.09.011. Epub 2018 Oct 24.

¹ Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France; Inserm UMR1043, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France.
² Laboratory of Virology, CHU Purpan, Toulouse, France; Inserm UMR1043, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France; Université Paul Sabatier, Toulouse, France.
³ Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France.
⁴ Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France; Inserm UMR1043, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France; Université Paul Sabatier, Toulouse, France. Electronic address: kamar.n@chu-toulouse.fr.

No abstract available

Keywords: Duration; Hepatitis E virus; Ribavirin; Stools; Sustained virological response; Transplantation.

Publication types